Results

Total Results: 601 records

Showing results for "cardiac".
Users also searched for: ekg

  1. effectivehealthcare-admin.ahrq.gov/products/nv-hap/protocol
    November 01, 2024 - Association between perioperative chlorhexidine oral care and postoperative pneumonia in non-cardiac
  2. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/mhs-iv-nv-hap-protocol.pdf
    August 05, 2024 - Association between perioperative chlorhexidine oral care and postoperative pneumonia in non- cardiac
  3. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/hypertension-pulmonary-arterial_disposition-comments.pdf
    April 25, 2013 - gathered many articles comparing the diagnostic accuracy of lab tests or echocardiography versus cardiac … Public Reviewer - ACCP 9 Results P106: last paragraph: “a significant improvement in cardiac index … The Channick, 2001, study abstract states “The cardiac index was 1.0 L min(-1) m(-2) (95% CI 0.6-1.4 … Whether echocardiography alone without routine cardiac catheterization and laboratory tests can be used … For example, practitioners have become less inclined to perform cardiac catheterizations and rely more
  4. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/atrial-fibrillation_disposition-comments.pdf
    June 28, 2013 - Recurrence of AF at 12 months o Development of cardiomyopathy Final outcomes: o Mortality (all-cause, cardiac … places where the authors state “was moderate strength of evidence” for outcomes such as all-cause or cardiac … with no more than mild structural heart disease) and for a surgical Maze procedure at time of other cardiac … surgery as opposed to the cardiac surgery alone in reducing AF recurrences” places a heavy emphasis
  5. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_surveillance.pdf
    April 01, 2013 - conventional PCI 25 trials including 5,534 patients Major adverse cardiac events were significantly
  6. effectivehealthcare-admin.ahrq.gov/products/high-cholestorol-medicines-update/research-protocol
    December 01, 2019 - new diagnoses of AKI; and CKD (investigator-defined) Composite outcomes (e.g., major adverse cardiac … patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac
  7. effectivehealthcare-admin.ahrq.gov/products/blood-clots-hip-knee-surgery/research-protocol
    December 01, 2019 - prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac … consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac
  8. effectivehealthcare-admin.ahrq.gov/sites/default/files/adhd_executive.pdf
    October 01, 2011 - The clinically significant ECG changes noted in 1 percent of children may warrant increased cardiac … Monitoring of cardiac status may be indicated since approximately 1% of participants showed ECG changes … On this topic, health administrative data suggest that neither cardiac events among those aged 20 years
  9. effectivehealthcare-admin.ahrq.gov/sites/default/files/tech-brief-38-chronic-conditions-comments.pdf
    March 01, 2021 - Peer Reviewer #2 Results In the section on cardiac arrhythmias (page 55), were data from current/ … I see it was discussed in the sections on Coronary Artery Disease and Cardiac Arrhythmias. … For example, pacemakers and implanted cardiac devices measure health outcomes and health trend data … obesity, diabetes, prevention, sleep apnea, hypertension, coronary artery disease, heart failure, cardiac
  10. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/preoperative-testing_disposition-comments.pdf
    January 29, 2014 - Effectiveness of non- cardiac preoperative testing in non-cardiac elective surgery: a systematic review
  11. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/high-cholestorol-medicines-update_research-protocol.pdf
    December 31, 2013 - plaque volume, arterial calcification, and/or measure of Composite outcomes (e.g., major adverse cardiac … have average or  lower-­‐than-­‐ average cholesterol concentrations, in the Anglo-­‐Scandinavian Cardiac
  12. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/coronary-artery-stenting_disposition-comments.pdf
    February 26, 2013 - The DEFER study demonstrated that the risk of cardiac death or myocardial infarction related to a functionally … for deferring PCI in patients with multivessel disease and lesion FFR > 0.80, with reduced rates of cardiac
  13. effectivehealthcare-admin.ahrq.gov/products/psoriasis-chronic/research-protocol
    December 01, 2019 - (Hoffmann-La Roche) Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, … Prophylaxis of organ rejection in patients receiving allogeneic renal, cardiac, or hepatic transplants
  14. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/horizon-scan_research-2015.pdf
    January 01, 2015 - For example, in considering a new transcathether cardiac valve in development for a new clinical indication … , we considered as a proxy the average cost of new and novel cardiac valves or devices that entered … about $75,000 per patient (without complications) for a minimally invasive procedure using a novel cardiac … Assuming that 650,000 patients who are at risk of developing CIN after cardiac catheterization procedures … conversion of touch surfaces in critical care units, with about 70,000 adult intensive care beds (cardiac
  15. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2023-surv-rep-4-table-E-5.xlsx
    January 01, 2023 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77) Cardiac
  16. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cannabis-2022-surv-rep-4-table-F5.xlsx
    January 01, 2022 - treatment related adverse event: 21.1% (71/337) vs. 35.0% (118/337), RR 0.60 (95% CI 0.47 to 0.77) Cardiac
  17. effectivehealthcare-admin.ahrq.gov/sites/default/files/vte-protocol-8-4-10.pdf
    February 01, 2008 - prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac … consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac
  18. effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/blood-clots-hip-knee-surgery_research-protocol.pdf
    February 01, 2008 - prophylaxis and/or treatment of the thromboembolic complications associated with atrial fibrillation and/or cardiac … consumptive coagulopathies (disseminated intravascular coagulation); prevention of clotting in arterial and cardiac
  19. effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_disposition-comments.pdf
    January 01, 2014 - What is missing is that the majority of patients presenting to ED with chest pain have non-cardiac … According to current definitions of early invasive therapy, the delay to cardiac catheterization in … For the KQ 2 GPI analysis, any study that prohibited cardiac catheterization or PCI within a defined … population given that there can be subjectivity in a clinician’s definition or differing thresholds for cardiac
  20. effectivehealthcare-admin.ahrq.gov/products/renal-update/research-protocol
    January 01, 2020 - events, including flash pulmonary edema (including hospitalization) Other cardiovascular events (cardiac

Search the AHRQ Archive

Information and reports more than 5 years old may be found in the AHRQ Archive site.

Search Archive

Search Within A Specific AHRQ Site

You selected to view results for the following site: